微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 46.03% | -9.05% | 0.42% | 11/51 | 35.76% | 南华生物 | 68.03% | 行业排名> |
| 2024-06-30 | 45.84% | -8.87% | -6.38% | 12/51 | 35.89% | 百诚医药 | 68.75% | 行业排名> |
| 2024-03-31 | 48.97% | 1.65% | -0.13% | 9/51 | 35.75% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 49.03% | 2.05% | -3.13% | 10/51 | 38.13% | 药康生物 | 67.61% | 行业排名> |
| 2023-09-30 | 50.62% | 5.4% | 0.63% | 8/51 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 50.3% | 6.09% | 4.42% | 7/51 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 48.17% | 108.24% | 0.25% | 10/51 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 48.05% | 4.37% | 0.05% | 11/51 | 40.1% | 药康生物 | 71.38% | 行业排名> |
| 2022-09-30 | 48.02% | 17.61% | 1.29% | 11/51 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 47.41% | 5.05% | 2.99% | 14/51 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2021-12-31 | 46.04% | 9.2% | 2% | 20/51 | 41.94% | 药康生物 | 76.7% | 行业排名> |
| 2021-06-30 | 45.13% | 2% | 7.05% | 23/51 | 42.6% | 药康生物 | 74.33% | 行业排名> |
| 2020-12-31 | 42.16% | 4.82% | 3.26% | 27/51 | 38.51% | 南华生物 | 84.53% | 行业排名> |
| 2020-09-30 | 40.83% | 2% | 76.51% | 19/51 | 37.76% | 南华生物 | 83.19% | 行业排名> |
| 2020-03-31 | 23.13% | 2% | -42.49% | 24/51 | 33.2% | 南华生物 | 83.9% | 行业排名> |
| 2019-12-31 | 40.22% | -1.48% | -1.48% | 28/51 | 42.94% | 成都先导 | 79.36% | 行业排名> |
| 2018-12-31 | 40.83% | -2.6% | -2.6% | 28/51 | 42.09% | 成都先导 | 75.92% | 行业排名> |
| 2017-12-31 | 41.91% | 2% | 2% | 17/51 | 40.94% | 南华生物 | 78.74% | 行业排名> |